SCHEMBL313348

SCHEMBL313348

CCOC(=O)Nc1cc(O)ncc1-c1cc(=O)c2c(O)cccc2o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.49
AR P10275 6/20 0.45
MAOB P27338 1/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
EGFR P00533 1/20 0.43
RET P07949 1/20 0.43
KDR P35968 1/20 0.43
ABL1 P00519 5/20 0.42
CYP3A4 P08684 4/20 0.42
MAPT P10636 4/20 0.42
ALOX15 P16050 2/20 0.42
CYP1A1 P04798 2/20 0.42
CYP1A2 P05177 2/20 0.42
ALDH1A1 P00352 1/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1B1 Q16678 1/20 0.42
FTO Q9C0B1 1/20 0.42
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312009 0.87 KDM4E (0.58) MAOBMEN1KMT2ACYP3A4MAPT
SCHEMBL311723 0.85 HPGD (0.43) MAOBMEN1KMT2ACYP3A4MAPT
SCHEMBL313004 0.85 ATM (0.52) ATMARMAOBMEN1KMT2A
SCHEMBL313038 0.82 HPGD (0.46) MAOBMEN1KMT2ACYP3A4MAPT
SCHEMBL311513 0.82 AR (0.45) ATMARMAOBMEN1KMT2A
SCHEMBL312841 0.82 AKR1B1 (0.50) MAOBMEN1KMT2ACYP3A4ALOX15
SCHEMBL311987 0.81 ATM (0.50) ATMARMAOBMEN1KMT2A
SCHEMBL311620 0.77 AKR1B1 (0.43) MAOBMEN1KMT2ACYP3A4ALOX15
SCHEMBL312748 0.77 TYR (0.44) MAOBEGFRRETKDRABL1
SCHEMBL312670 0.77 HPGD (0.42) MAOBMEN1KMT2ACYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed